Verquvo (vericiguat)

pCPA File Number: 22399
Negotiation Status:
Concluded with an LOI
Indication(s):
For the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction who are stabilized after a recent heart failure decompensation event requiring hospitalization and/or intravenous diuretic therapy
Sponsor/Manufacturer:
Bayer Inc.
CDA-AMC Project Number:
SR0758
pCPA Engagement Letter Issued:
Negotiation Process Concluded: